Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Johnson PharmacareBOM:532154 -4.17%13 9-Day RSI is 39.03 as of Aug. 14, 2026. GuruFocus rates BOM:532154 with a GF Score™ of 13/100. The stock has 4 warning signs investors should review. Among 602 Diversified Financial Services companies, Johnson Pharmacare ranks better than 83.72% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for Johnson Pharmacare's 9-Day RSI or its related term are showing as below:
BOM:532154's 9-Day RSI is ranked better than 83.72% of 602
companies
in the Diversified Financial Services industry
Industry Median: 56.09
vs BOM:532154: 39.03
Johnson Pharmacare (BOM:532154) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Johnson Pharmacare 9-Day RSI Related Terms
BOM:532154 vs XXI, CCXI, DMII: 9-Day RSI Comparison
For the Shell Companies subindustry, Johnson Pharmacare's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Johnson Pharmacare 9-Day RSI vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Johnson Pharmacare's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Johnson Pharmacare's 9-Day RSI falls into.
Johnson Pharmacare (BOM:532154) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Johnson Pharmacare (BOM:532154) has a 9-Day RSI of 39.03 as of Aug. 14, 2026. According to the industry distribution chart, Johnson Pharmacare ranks #98 out of 602 companies in the Diversified Financial Services industry, placing it in the top 16.3%.
Is Johnson Pharmacare's 9-Day RSI too high?
Johnson Pharmacare's current 9-Day RSI is 39.03. The Diversified Financial Services industry median 9-Day RSI is 56.09. Johnson Pharmacare's value of 39.03 is 30.4% below this industry median. Based on the distribution chart, Johnson Pharmacare ranks #98 out of 602 companies in the Diversified Financial Services industry, which is in the top quartile — a strong position relative to peers. Overall, Johnson Pharmacare has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Johnson Pharmacare's 9-Day RSI compare to XXI and CCXI?
According to the Diversified Financial Services industry distribution chart, Johnson Pharmacare ranks #98 out of 602 companies for 9-Day RSI. This places Johnson Pharmacare in the top 16% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 56.09. Johnson Pharmacare's value of 39.03 is 30.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Diversified Financial Services company?
The median 9-Day RSI among Diversified Financial Services companies is 56.09, based on 602 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Johnson Pharmacare's current 9-Day RSI of 39.03 is 30.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Diversified Financial Services industry, the median 9-Day RSI is 56.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Johnson Pharmacare's current 9-Day RSI is 39.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson Pharmacare stock overvalued right now?
Johnson Pharmacare (BOM:532154) has a current 9-Day RSI of 39.03. The current 9-Day RSI is 39.03 and 30.4% below the Diversified Financial Services industry median of 56.09. Johnson Pharmacare's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Johnson Pharmacare (BOM:532154), the current 9-Day RSI is 39.03 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532154 has been successfully added to your 
